2021
DOI: 10.1080/13816810.2021.1910963
|View full text |Cite
|
Sign up to set email alerts
|

Current concepts on diffuse choroidal hemangioma in Sturge Weber syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 60 publications
0
14
0
Order By: Relevance
“…In 2019, Bichsel et al [ 89 ] showed that the mutation found in most sporadic capillary malformations, GNAQ R183Q, was present in the choroidal vessels at a similar frequency to that found in SWS brain tissue, suggesting an analogous choroidal capillary malformation cause. Anti-VEGF use alone is neither resolutive nor indicated, but recent publications are showing the utility of adding anti-VEGF agents to PDT to counter the effect of PDT-induced high VEGF levels [ 90 ]. These results indicate that CNV and choroidal capillary malformations follow different pathways, but the development of new vessel complexes in SWS could still represent a potential complication [ 80 ].…”
Section: Resultsmentioning
confidence: 99%
“…In 2019, Bichsel et al [ 89 ] showed that the mutation found in most sporadic capillary malformations, GNAQ R183Q, was present in the choroidal vessels at a similar frequency to that found in SWS brain tissue, suggesting an analogous choroidal capillary malformation cause. Anti-VEGF use alone is neither resolutive nor indicated, but recent publications are showing the utility of adding anti-VEGF agents to PDT to counter the effect of PDT-induced high VEGF levels [ 90 ]. These results indicate that CNV and choroidal capillary malformations follow different pathways, but the development of new vessel complexes in SWS could still represent a potential complication [ 80 ].…”
Section: Resultsmentioning
confidence: 99%
“…Mutations in G protein alpha subunits, GNAQ and GNA11, and more rarely CYSLTR2 and PCLB4, are most commonly associated with uveal nevus and melanoma and more rarely with cutaneous or conjunctival melanoma 16 , 17 but they have also been associated with choroidal hemangioma, particularly in patients with Sturge-Weber syndrome. 18 They are thought to be mutually exclusive initiator mutations found in the majority of uveal melanomas but are not known to play a major role in uveal lymphoma. Secondary driver mutations including EIF1AX, SF3B1, SRSF2, and BAP1 correlate with patient outcome, and in the setting of an initiator GNAQ or GNA11 mutation, are likely indicative of a uveal melanoma.…”
Section: Discussionmentioning
confidence: 99%
“…Enhanced depth imaging optical coherence tomography (EDI-OCT) can show the choroid in vivo, and it can be seen that choroidal thickening occurs obviously in the eyes with DCH [23,24]. Fluorescein angiography (FFA) and indocyanine green angiography (ICGA) can present DCH better [25], but both are invasive and the cooperation of young patients can be challenging.…”
Section: Discussionmentioning
confidence: 99%